What does CUSIP 640268108 represent in this 13F holders report?

CUSIP 640268108 is the security identifier for NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in Q4 2017?

261 institutional investors reported NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value for Q4 2017. Use the holders table for investor-level position and value details.

NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

CUSIP: 640268108

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 28,811,441
Total 13F shares: 154,603,092
Share change: +157,862
Total reported value: $9,233,952,173
Put/Call ratio: 15%
Price per share: $59.72
Number of holders: 261
Value change: +$80,601,155
Number of buys: 138
Number of sells: 115

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018
Previous quarter: Q3 2017

Recent filing periods for CUSIP 640268108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
OppenheimerFunds, Inc.	13F	Company	86%	24,772,230	$594,534,000	—	30 Sep 2017	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	80%	23,142,222	$555,413,000	—	30 Sep 2017	13F
BlackRock Finance, Inc.	13F	Company	73%	21,000,119	$504,003,000	—	30 Sep 2017	13F
VANGUARD GROUP INC	13F	Company	50%	14,303,480	$343,284,000	—	30 Sep 2017	13F
Camber Capital Management LP	13F	Company	18%	5,200,000	$124,800,000	—	30 Sep 2017	13F
STATE STREET CORP	13F	Company	14%	3,968,428	$95,246,000	—	30 Sep 2017	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	13%	3,632,419	$87,178,000	—	30 Sep 2017	13F
Invesco Ltd.	13F	Company	13%	3,612,747	$86,706,000	—	30 Sep 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	12%	3,329,281	$79,903,000	—	30 Sep 2017	13F
NORGES BANK	13F	Company	9.4%	2,713,717	$65,129,000	—	30 Sep 2017	13F
JPMORGAN CHASE & CO	13F	Company	8.1%	2,324,346	$55,040,000	—	30 Sep 2017	13F
BRIDGER MANAGEMENT, LLC	13F	Company	7.9%	2,274,661	$54,592,000	—	30 Sep 2017	13F
Bank of New York Mellon Corp	13F	Company	7.2%	2,062,186	$49,493,000	—	30 Sep 2017	13F
NORTHERN TRUST CORP	13F	Company	6.7%	1,919,412	$46,066,000	—	30 Sep 2017	13F
FIRST TRUST ADVISORS LP	13F	Company	5.7%	1,656,210	$39,749,000	—	30 Sep 2017	13F
PointState Capital LP	13F	Company	5.5%	1,580,300	$37,927,000	—	30 Sep 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	5.1%	1,458,007	$34,992,000	—	30 Sep 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	5%	1,432,013	$34,368,000	—	30 Sep 2017	13F
DEUTSCHE BANK AG\	13F	Company	4.4%	1,265,295	$30,365,000	—	30 Sep 2017	13F
Artal Group S.A.	13F	Company	4.3%	1,250,000	$30,000,000	—	30 Sep 2017	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	4.3%	1,237,309	$29,695,000	—	30 Sep 2017	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	4.1%	1,182,422	$28,378,000	—	30 Sep 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.1%	1,177,005	$28,248,000	—	30 Sep 2017	13F
Duquesne Family Office LLC	13F	Company	4%	1,166,100	$27,986,000	—	30 Sep 2017	13F
FEDERATED HERMES, INC.	13F	Company	3.6%	1,028,200	$24,677,000	—	30 Sep 2017	13F
Rubric Capital Management LP	13F	Company	3.5%	996,835	$23,924,000	—	30 Sep 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	3.3%	949,025	$22,776,000	—	30 Sep 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	3.3%	944,883	$22,677,000	—	30 Sep 2017	13F
Rhenman & Partners Asset Management AB	13F	Company	3%	866,194	$20,789,000	—	30 Sep 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	2.9%	833,747	$20,010,000	—	30 Sep 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	2.8%	792,782	$19,027,000	—	30 Sep 2017	13F
SYSTEMATIC FINANCIAL MANAGEMENT LP	13F	Company	2.6%	745,979	$17,903,000	—	30 Sep 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	2.4%	703,282	$16,879,000	—	30 Sep 2017	13F
MORGAN STANLEY	13F	Company	2.4%	703,044	$16,873,000	—	30 Sep 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	2.3%	674,346	$16,184,000	—	30 Sep 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	1.9%	553,989	$13,296,000	—	30 Sep 2017	13F
Tamarack Advisers, LP	13F	Company	1.9%	550,000	$13,200,000	—	30 Sep 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.9%	545,687	$13,096,000	—	30 Sep 2017	13F
FMR LLC	13F	Company	1.8%	525,453	$12,611,000	—	30 Sep 2017	13F
First Light Asset Management, LLC	13F	Company	1.7%	503,193	$12,077,000	—	30 Sep 2017	13F
Granahan Investment Management, LLC	13F	Company	1.7%	483,800	$11,611,000	—	30 Sep 2017	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.6%	458,997	$11,016,000	—	30 Sep 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.4%	413,245	$9,918,000	—	30 Sep 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1.4%	412,946	$9,910,704	—	30 Sep 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	1.3%	378,711	$9,089,000	—	30 Sep 2017	13F
CREDIT SUISSE AG/	13F	Company	1.3%	366,506	$8,796,000	—	30 Sep 2017	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	1.3%	364,756	$8,754,000	—	30 Sep 2017	13F
BLAIR WILLIAM & CO/IL	13F	Company	1.2%	351,645	$8,439,000	—	30 Sep 2017	13F
RHUMBLINE ADVISERS	13F	Company	1.1%	317,292	$7,615,000	—	30 Sep 2017	13F
Legal & General Group Plc	13F	Company	1.1%	306,478	$7,348,000	—	30 Sep 2017	13F

Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q4 2017

As of 31 Dec 2017, NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by 261 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 154,603,092 shares. The largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., Vanguard Group Inc, OppenheimerFunds, Inc., FMR LLC, STATE STREET CORP, PointState Capital LP, JANUS HENDERSON GROUP PLC, Camber Capital Management LLC, and NORGES BANK. This page lists 261 institutional shareholders reporting positions in this security for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders

203

Q4 2017 holders

261

Holder diff

Investor	Q3 2017 Shares	Q4 2017 Shares	Share Diff	Share Chg %	Q3 2017 Value $	Q4 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.